BD Launches New AI-enabled Solutions to Drive Connectivity Across Healthcare Settings
BD (NYSE: BDX) on Oct 20, 2025 launched the BD Incada™ Connected Care Platform, an AI-enabled, AWS-based cloud platform that unifies BD device data into a single ecosystem and supports analytics for nearly 3 million smart connected BD devices.
At the same time BD introduced the next-generation BD Pyxis™ Pro Dispensing Solution, a stackable automated medication dispenser that adds capacity (up to 538 multi-access or 98 secure pockets) in a similar footprint, and adds security, RFID badge scanning, wireless barcode scanning and illuminated bins.
The combined offering emphasizes enterprise-wide medication visibility, natural-language analytics, customizable dashboards, and secure cloud storage aimed at reducing medication waste, improving labor efficiency, and speeding point-of-care access. BD notes the Pyxis system processes about 9.8 million transactions per day.
BD (NYSE: BDX) il 20 ottobre 2025 ha lanciato la BD Incada™ Connected Care Platform, una piattaforma cloud basata su AWS e abilitata all'AI che unisce i dati dei dispositivi BD in un unico ecosistema e supporta analisi per quasi 3 milioni di dispositivi BD intelligenti connessi.
Contemporaneamente BD ha presentato la prossima generazione della BD Pyxis™ Pro Dispensing Solution, un dispenser automatico di medicinali impilabile che aumenta la capacità (fino a 538 accessi multipli o 98 tasche sicure) in una impronta simile, e aggiunge sicurezza, lettura badge RFID, scansione codice a barre wireless e vassoi illuminati.
L'offerta combinata mette in evidenza la visibilità dei farmaci a livello aziendale, analisi in linguaggio naturale, dashboard personalizzabili e archiviazione sicura nel cloud finalizzati a ridurre gli sprechi di farmaci, migliorare l'efficienza del personale e accelerare l'accesso al punto di cura. BD osserva che il sistema Pyxis elabora circa 9,8 milioni di transazioni al giorno.
BD (NYSE: BDX) el 20 de octubre de 2025 lanzó la BD Incada™ Connected Care Platform, una plataforma en la nube basada en AWS y habilitada para IA que unifica los datos de los dispositivos BD en un único ecosistema y respalda analíticas para casi 3 millones de dispositivos BD inteligentes y conectados.
Al mismo tiempo BD presentó la siguiente generación de la BD Pyxis™ Pro Dispensing Solution, un dispensador automático de medicamentos apilable que añade capacidad (hasta 538 accesos múltiples o 98 bolsillos seguros) en una huella similar, y añade seguridad, escaneo de tarjetas RFID, escaneo de códigos de barras por radio y bandejas iluminadas.
La oferta combinada enfatiza la visibilidad de la medicación a nivel empresarial, análisis en lenguaje natural, paneles de control personalizables y almacenamiento seguro en la nube destinados a reducir el desperdicio de medicamentos, mejorar la eficiencia del personal y acelerar el acceso en punto de atención. BD señala que el sistema Pyxis procesa aproximadamente 9,8 millones de transacciones por día.
BD (NYSE: BDX) 2025년 10월 20일 BD Incada™ Connected Care Platform를 출시했다. AI 기반의 AWS 클라우드 플랫폼으로 BD 디바이스 데이터를 하나의 생태계로 통합하고 거의 300만 대의 스마트 연결 BD 디바이스에 대한 분석을 지원한다.
동시에 BD는 차세대 BD Pyxis™ Pro Dispensing Solution을 발표했다. 다단식 자동 약품 디스펜서로 같은 풋프린트에서 용량을 늘리고(멀티 액세스 538 또는 98개의 보안 포켓), 보안, RFID 배지 스캔, 무선 바코드 스캔 및 조명 표지함을 추가한다.
통합 기능은 기업 차원의 의약품 가시성, 자연어 분석, 사용자 정의 대시보드 및 안전한 클라우드 스토리지에 중점을 두며, 의약품 낭비를 줄이고 인력 효율성을 높이며 진료 현장 접근 속도를 높이는 것을 목표로 한다. BD는 Pyxis 시스템이 하루 약 980만 건의 거래를 처리한다고 언급한다.
BD (NYSE: BDX) a lancé le BD Incada™ Connected Care Platform, le 20 octobre 2025, une plateforme cloud basée sur AWS et assistée par l'IA qui unit les données des dispositifs BD en un seul écosystème et prend en charge les analyses pour près de 3 millions de dispositifs BD intelligents et connectés.
En parallèle, BD a présenté la prochaine génération de la BD Pyxis™ Pro Dispensing Solution, un distributeur automatique de médicaments empilable qui augmente la capacité (jusqu'à 538 accès multiples ou 98 poches sécurisées) dans une empreinte similaire, et ajoute sécurité, scan d badges RFID, scan de codes-barres sans fil et bacs éclairés.
L'offre combinée met l'accent sur la visibilité des médicaments à l'échelle de l'entreprise, l'analytique en langage naturel, des tableaux de bord personnalisables et un stockage cloud sécurisé visant à réduire le gaspillage de médicaments, améliorer l'efficacité du personnel et accélérer l'accès au point de soins. BD note que le système Pyxis traite environ 9,8 millions de transactions par jour.
BD (NYSE: BDX) hat am 20. Oktober 2025 die BD Incada™ Connected Care Platform eingeführt, eine KI-unterstützte, AWS-basierte Cloud-Plattform, die BD-Geräte-Daten in ein einziges Ökosystem vereint und Analytik für nahezu 3 Millionen intelligente verbundene BD-Geräte unterstützt.
Zur gleichen Zeit führte BD die nächste Generation der BD Pyxis™ Pro Dispensing Solution ein, einen stapelbaren automatischen Medikamentenspender, der Kapazität erhöht (bis zu 538 Mehrfachzugriffe oder 98 sichere Fächer) bei ähnlicher Grundfläche und Sicherheit, RFID-Ausweis-Scan, drahtloses Barcodescannen und beleuchtete Fächer hinzufügt.
Das kombinierte Angebot betont unternehmensweite Medikamentenklarheit, Analytik in natürlicher Sprache, anpassbare Dashboards und sicheren Cloud-Speicher, mit dem Ziel, Medikamentenverschwendung zu reduzieren, die Arbeitsabläufe zu verbessern und den Zugang am Point-of-Care zu beschleunigen. BD weist darauf hin, dass das Pyxis-System etwa 9,8 Millionen Transaktionen pro Tag verarbeitet.
BD (NYSE: BDX) في 20 أكتوبر 2025 أطلق BD Incada™ Connected Care Platform، منصة سحابية مدعومة بالذكاء الاصطناعي ومبنية على AWS توحد بيانات أجهزة BD في منظومة واحدة وتدعم التحليلات لما يقرب من 3 ملايين جهاز BD ذكي متصل.
وفي الوقت نفسه قدمت BD الجيل التالي من BD Pyxis™ Pro Dispensing Solution، وهو مُوزّع أدوية آلي قابل للتكديس يضيف سعة (حتى 538 وصولاً متعددًا أو 98 جيباً آمناً) ضمن أُثر footprint مماثل، ويضيف أمانًا، ومسح بطاقة RFID، ومسح باركود لاسلكي ورفوف مضاءة.
العرض المشترك يؤكد رؤية الأدوية على مستوى المؤسسة، والتحليلات باللغة الطبيعية، ولوحات معلومات قابلة للتخصيص وتخزين سحابي آمن يهدف إلى تقليل هدر الأدوية، وتحسين كفاءة العمل، وتسريع الوصول إلى مكان الرعاية. تذكر BD أن نظام Pyxis يعالج نحو 9.8 ملايين معاملة يوميًا.
BD (NYSE: BDX) 于2025年10月20日推出了BD Incada™ Connected Care Platform,一款AI驱动的、基于AWS的云平台,将BD设备数据整合到一个生态系统中,并支持对近300万台智能连接BD设备的分析。
同时,BD推出了下一代BD Pyxis™ Pro Dispensing Solution,一种可堆叠的自动药品分发器,在相同占地基础上增加容量(多达538个多入口或98个安全口袋),并增加安全性、RFID胸牌扫描、无线条码扫描和照明箱。
该组合产品强调企业级药品可视性、自然语言分析、可定制仪表板,以及安全云存储,旨在降低药物浪费、提高手术室/工作效率,并加速就医点的访问。BD指出,Pyxis系统每天处理约980万笔交易。
- AI-enabled analytics on AWS supports natural-language search and on-demand insights
- Scalable platform designed for nearly 3 million smart connected BD devices
- Up to 538 multi-access pockets or 98 secure pockets in same footprint
- 9.8 million daily transactions on Pyxis devices indicating broad installed base
- New access features: RFID badge scanning, wireless barcode scanners, illuminated bins
- None.
Insights
BD's cloud AI platform and next‑gen Pyxis aim to unify device data and speed medication access across care settings.
The announcement describes the BD Incada™ Connected Care Platform as an AWS‑built, scalable, AI‑enabled cloud system that aggregates data from BD devices and offers natural language analytics for on‑demand insights. The platform explicitly targets enterprise visibility into medication inventory, waste reduction, labor efficiency and user‑customizable dashboards, tying analytics to operational actions.
Key dependencies and risks include successful secure integration of data from diverse device types, real‑world performance of the AI analytics at the scale cited (nearly 3 million devices), and adoption by clinical teams who must change workflows to use dashboards and natural‑language queries effectively. Security and data governance will also matter given the cloud and device connectivity model.
Concrete items to watch: rollout and integration timelines for the BD Incada™ Platform and the next‑generation BD Pyxis™ Pro, actual deployment counts and usage metrics, and evidence that the platform reduces medication waste or improves labor efficiency within
Pyxis Pro's higher capacity and enhanced security plus cloud analytics target faster, safer medication delivery at scale.
The release highlights the BD Pyxis™ Pro Dispensing Solution with expanded capacity (up to 538 multi‑access or 98 secure pockets in a similar footprint), refrigerated-to-ambient storage flexibility, RFID and barcode workflows, and enhanced controlled‑substance controls. Combined with platform analytics, the offering links inventory visibility to point‑of‑care access.
Operational risks include change management for pharmacy and nursing workflows, validating security controls for controlled substances, and proving that increased capacity actually improves availability without creating inventory inefficiencies. Metrics claimed—such as integration with nearly 3 million devices and >9.8 million daily transactions on Pyxis systems—should be verified during pilot deployments.
Watch for metrics demonstrating reduced medication waste, improvements in medication retrieval times, controlled‑substance audit outcomes, and phased deployments reported by health systems over the next 6–12 months after the
"Our vision for the BD Incada™ Platform is to go beyond legacy connectivity to create meaningful connections across devices from infusion pumps to patient monitors to pharmacy robotics, and unify data from those solutions into one ecosystem, transforming data into clear, actionable insights for care teams," said Bilal Muhsin, EVP and President of BD Connected Care. "These launches represent key milestones in BD's Connected Care strategy, where we are uniquely positioned with our broad portfolio from pharmacy to bedside, to leverage game-changing technology to drive meaningful benefits for our customers."
AI-powered analytics to drive smarter, faster decisions
Built on Amazon Web Services' (AWS) on-demand cloud computing infrastructure, the BD Incada™ Platform leverages the latest in AI technologies, such as natural language search in analytics, and is scalable to meet the data volumes created by nearly 3 million smart connected BD devices. With Analytics in the BD Incada™ Platform, data from BD's leading medication management solutions now flows through a secure, cloud platform and enables:
- Enterprise-wide visibility into medication inventory, which helps clinicians identify patterns and ensure medication availability, reduce medication waste and improve labor efficiency
- The ability to ask natural language questions and receive AI-powered insights and analytics on demand
- User-customizable dashboards that empower frontline clinical teams to act on insights quickly
Flexible, secure storage to get the right medication to the right patient, faster
The new BD Pyxis™ Pro Dispensing Solution delivers smarter, more secure medication storage, which enables faster access at the point of care. The first-of-its-kind flexible, stackable device configuration offers more medication storage capacity to improve medication availability from refrigerated to ambient storage. The BD Pyxis™ Pro Dispensing Solution allows hospitals and health systems to easily adapt to the evolving needs of their patient populations, with features including:
- Expanded capacity in a similar footprint, enabling clinicians to add up to 538 multi-access or 98 secure pockets without taking more space in their medication rooms
- Enhanced security features to improve controlled substance management and medication safety efforts
- More efficient access, with RFID badge scanning, wireless barcode scanners and illuminated bins to streamline medication retrieval
"For over 35 years, the BD Pyxis™ System has been the backbone of medication management across hospitals and health systems, with more than 9.8 million transactions on BD Pyxis™ devices every day," said Connor Bates, Worldwide President for Medication Management Solutions at BD. "With the enhanced secure capacity, durability and AI-powered analytics of the next-generation BD Pyxis™ Pro Dispensing Solution, we're ushering in a transformative new era for medication management."
Together, the BD Incada™ Platform and BD Pyxis™ Pro Dispensing Solution sets a new standard for unified, data-driven healthcare operations.
About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics, and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiency, improve safety, and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson.
|
Contacts: |
|
|
Media: |
Investors: |
|
Fallon McLoughlin |
Adam Reiffe |
|
Director, Public Relations |
VP, Investor Relations |
|
201.258.0361 |
201.847.6927 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/bd-launches-new-ai-enabled-solutions-to-drive-connectivity-across-healthcare-settings-302588426.html
SOURCE BD (Becton, Dickinson and Company)